The Obesity ETF
Ticker: SLIM
Principal U.S. Listing
Exchange: The NASDAQ Stock Market LLC
SUMMARY PROSPECTUS DATED
FEBRUARY 28, 2020
Before you invest, you may want to review the Funds Prospectus, which contains more information about the
Fund and its risks. You can find the Funds Prospectus and other information about the Fund online at janushenderson.com/info. You can also get this information at no cost by calling a Janus Henderson representative at 1-877-335-2687 or by sending an email request to prospectusrequest@janushenderson.com.
The Board of Trustees of Janus Detroit Street Trust (the Trust) approved a plan to liquidate and terminate The Obesity ETF (the
Fund), effective on or about March 17, 2020 (the Liquidation Date). After the close of business on or about March 12, 2020, the Fund will no longer accept creation orders. Trading in the Fund will be halted prior to market
open on or about March 13, 2020. Proceeds of the liquidation are currently scheduled to be sent to shareholders on or about March 18, 2020. Termination of the Fund is expected to occur as soon as practicable following the liquidation. Prior to and
through the close of trading on The NASDAQ Stock Market LLC (NASDAQ) on March 12, 2020, the Fund will undertake the process of closing down and liquidating its portfolio. This process may result in the Fund holding cash and securities
that may not be consistent with its investment objective and strategies. During this period, the Fund is likely to incur higher tracking error than is typical for the Fund. Furthermore, during the time between market open on March 13, 2020 and the
Liquidation Date, because shares will not be traded on NASDAQ, there may not be a trading market for the Funds shares. Shareholders may sell shares of the Fund on NASDAQ until the market close on March 12, 2020 and may incur typical
transaction fees from their broker-dealer. Shares held as of the close of business on the Liquidation Date will be automatically redeemed for cash at the current net asset value. Proceeds of the redemption will be paid through the broker-dealer with
whom you hold shares of the Fund. Shareholders will generally recognize a capital gain or loss on the redemptions. The Fund may or may not, depending upon the Funds circumstances, pay one or more dividends or other distributions prior to or
along with the redemption payments. Please consult your personal tax advisor about the potential tax consequences.
Beginning on January 1, 2021, as
permitted by regulations adopted by the Securities and Exchange Commission, paper copies of the Funds shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports from your broker-dealer or other financial intermediary (such as a bank). Instead, the reports will be made available on a website, and you will be notified by mail each time a report is posted and provided with a website
link to access the report.
If you already elected to receive shareholder reports electronically, you will not be affected by this change and you
need not take any action. You may elect to receive shareholder reports and other communications from the Fund electronically by contacting your broker-dealer or other financial intermediary.
You may elect to receive all future reports in paper free of charge by contacting your broker-dealer or other
financial intermediary. Your election to receive reports in paper will apply to all Funds held in your account at your broker-dealer or other financial intermediary.
The Obesity ETF seeks investment results that correspond generally to the performance, before fees and expenses, of an
index which is designed to track the performance of companies globally that are positioned to profit from servicing the obese, including biotechnology, pharmaceutical, health care and medical device companies whose business is focused on obesity and
obesity related disease including diabetes, high blood pressure, cholesterol, heart disease, stroke, and sleep apnea, and companies focused on weight loss programs, weight loss supplements, or plus sized apparel.
1½The Obesity ETF
|
FEES AND EXPENSES OF THE FUND
|
This table describes the fees and expenses that you may pay if you buy and hold shares of the Fund. Investors may pay brokerage
commissions on their purchases and sales of Fund shares, which are not reflected in the table or in the example below.
|
|
|
|
|
ANNUAL FUND OPERATING EXPENSES
(expenses that you pay each year as a percentage of the value of your investment)
|
|
Management Fees(1)
|
|
|
0.35%
|
|
Other Expenses
|
|
|
0.00%
|
|
Total Annual Fund Operating Expenses
|
|
|
0.35%
|
|
(1)
|
The Funds Management Fee is a unitary fee that is designed to pay substantially all operating
expenses, except for distribution fees (if any), brokerage expenses or commissions, interest, dividends, taxes, litigation expenses, acquired fund fees and expenses (if any), and other extraordinary expenses not incurred in the ordinary course of
the Funds business.
|
EXAMPLE:
The Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other funds. The Example assumes that you invest
$10,000 in the Fund for the time periods indicated and then sell all of your shares at the end of those periods. The Example also assumes that your investment has a 5% return each year and that the Funds operating expenses remain the same.
Although your actual costs may be higher or lower, based on these assumptions your costs would be:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Year
|
|
|
3 Years
|
|
|
5 Years
|
|
|
10 Years
|
|
|
|
$
|
36
|
|
|
$
|
113
|
|
|
$
|
197
|
|
|
$
|
443
|
|
Portfolio Turnover: The Fund pays transaction costs, such as commissions, when it buys and sells securities
(or turns over its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Fund shares are held in a taxable account. These costs, which are not reflected in annual fund
operating expenses or in the Example, affect the Funds performance. During the most recent fiscal year, the Funds portfolio turnover rate was 22% of the average value of its portfolio.
|
PRINCIPAL INVESTMENT STRATEGIES
|
The Fund pursues its investment objective by investing at least 80% of its net assets (plus any borrowings for investment
purposes) in the stocks that comprise the Solactive Obesity Index (Underlying Index). The Underlying Index is designed to track the performance of companies globally that are positioned to profit from servicing the obese, including
biotechnology, pharmaceutical, health care and medical device companies whose business is focused on obesity and obesity related disease including diabetes, high blood pressure, cholesterol, heart disease, stroke, and sleep apnea, and companies
focused on weight loss programs, weight loss supplements, or plus sized apparel. Under normal circumstances, the Fund expects to invest substantially all of its assets in securities included in the Underlying Index, using a replication strategy as
discussed below. The Fund may invest in companies of any capitalization, although at least 90% of the companies will have a capitalization of at least $100 million. The Fund may invest in foreign issuers, including emerging markets. Stocks included
in the Underlying Index may include common shares traded on local exchanges, American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). ADRs and GDRs represent ownership interests in shares of foreign
companies that are held in financial institution custodial accounts, and are traded on exchanges in the United States and around the world.
The Fund is
classified as nondiversified, which allows it to hold larger positions in a smaller number of companies, compared to a fund that is classified as diversified.
The Underlying Index, the Solactive Obesity Index, was created by and is maintained by Solactive AG (Solactive or the Index Provider).
The Underlying Index is reconstituted on a semi-annual basis, rebalanced on a quarterly basis, and the Fund is rebalanced quarterly based on changes to the Underlying Index. The Fund uses a passive, index-based approach in seeking
performance that corresponds to the performance of the Underlying Index. The underlying securities are weighted according to their market capitalization relative to other securities in the Underlying Index, and capped so that no security will
represent more than 20% of the Underlying Index at the time of an index reconstitution or rebalance. Due to market movement between rebalancing and reconstitution of the Underlying Index, an underlying security may represent more than 20% of the
Underlying Index at any given time, and thus may represent more than 20% of the Funds assets at any given time.
2½The Obesity ETF
The Fund will generally use a replication methodology, meaning it will invest in the securities composing the
Underlying Index in proportion to the weightings in the Underlying Index. However, the Fund may utilize a sampling methodology under various circumstances in which it may not be possible or practicable to purchase all of the securities in the
Underlying Index. Janus Capital expects that over time, if the Fund has sufficient assets, the correlation between the Funds performance, before fees and expenses, and that of the Underlying Index will be 95% or better. A figure of 100% would
indicate perfect correlation.
Under normal circumstances, the Fund expects to invest substantially all of its assets in securities included in the
Underlying Index, although it may invest up to 20% its assets in other securities that Janus Capital believes will help the Fund track the Underlying Index. Such investments include stocks, shares of other investment companies, cash and cash
equivalents, including money market funds.
To the extent the Underlying Index concentrates (i.e., holds 25% or more of its total assets) in the securities
of a particular industry or group of industries, the Fund will concentrate its investments to approximately the same extent as the Underlying Index. As of February 1, 2020, approximately 64% of the Underlying Index was represented by companies in
the Health Care Equipment & Services Industry. For more recent information, see the Funds daily portfolio holdings posted on the ETF portion of the Janus Henderson website.
The Fund may lend portfolio securities on a short-term or long-term basis, in an amount equal to up to one-third of its total assets as determined at the time
of the loan origination.
|
PRINCIPAL INVESTMENT RISKS
|
The Funds returns and yields will vary, and you could lose money. The principal risks and special considerations
associated with investing in the Fund are set forth below.
Market Risk. The value of the Funds portfolio may decrease if
the value of an individual company or security, or multiple companies or securities, in the portfolio decreases. Further, regardless of how well individual companies or securities perform, the value of the Funds portfolio could also decrease
if there are deteriorating economic or market conditions. It is important to understand that the value of your investment may fall, sometimes sharply, in response to changes in the market, and you could lose money. Market risk may affect a single
issuer, industry, economic sector, or the market as a whole. The Underlying Index has exposure to the small-, mid- and/or large capitalization sectors of the stock market, and therefore at times the Fund may underperform the overall stock market.
Equity Investing Risk. The Funds investment in the securities composing the Underlying Index involves risks of investing in
a portfolio of equity securities, such as market fluctuations, changes in interest rates and perceived trends in stock prices.
Concentration
Risk. The Fund focuses its investments in companies that service the obese, many of which are in the health care sector. Because of this, companies in the Funds portfolio may share common characteristics and may be more
sensitive to factors such as government regulation and cost containment measures, rapid changes in technology, and product cycles. As a result, the Fund may be subject to greater risks and the value of its investments may fluctuate more than a fund
that does not focus its investments. In addition, the Funds assets will generally be concentrated in an industry or group of industries to the extent that the Funds Underlying Index concentrates in a particular industry or group of
industries. In addition, to the extent the Fund invests a substantial portion of its assets in an industry or group of industries, market or economic factors impacting that industry or group of industries could have a significant effect on the value
of the Funds investments. Companies in the same or similar industries may share common characteristics and are more likely to react similarly to industry-specific market or economic developments. Additionally, the Funds performance may
be more volatile when the Funds investments are less diversified across industries. The Funds assets will not be concentrated if the Underlying Index does not concentrate in a particular industry or group of industries.
Health Care Equipment & Services Industry Risk. Health care equipment and services companies are affected by rising costs of
medical products, devices and services and the increased emphasis on the delivery of health care through outpatient services. Competition among health care equipment and services companies is high and can be significantly affected by extensive
government regulation or government reimbursement for medical expenses. The equipment and services may be subject to extensive litigation based on malpractice claims, product liability claims or other litigation. Medical equipment manufacturers are
heavily dependent on patent protection and the expiration of patents may adversely affect their profitability. Many new health care products are subject to the approval of the U.S. Food and Drug Administration (FDA), the process for
which is often long and expensive.
3½The Obesity ETF
Small- and Mid-Sized Companies Risk. The Funds investments in securities issued by
small- and mid-sized companies, which can include smaller, start-up companies offering emerging products or services, may involve greater risks than are customarily associated with larger, more established companies. Securities issued by small- and
mid-sized companies tend to be more volatile and somewhat more speculative than securities issued by larger or more established companies and may underperform as compared to the securities of larger companies. Securities issued by
micro-capitalization companies tend to be significantly more volatile, and more vulnerable to adverse business and economic developments, than those of larger companies. For example, small- and micro-capitalization companies may be more likely to
merge with or be acquired by another company, resulting in delisting of the securities held by the Fund.
Growth Securities
Risk. Securities of companies perceived to be growth companies may be more volatile than other stocks and may involve special risks. If the perception of a companys growth potential is not realized, the
securities purchased may not perform as expected, reducing the Funds returns. In addition, because different types of stocks tend to shift in and out of favor depending on market and economic conditions, growth stocks may perform
differently from the market as a whole, and other types of securities.
Foreign Exposure Risk. The Fund may have exposure to
foreign markets as a result of its investments in foreign securities, including investments in emerging markets, which can be more volatile than the U.S. markets. As a result, its returns and net asset value per share (NAV) may be
affected to a large degree by fluctuations in currency exchange rates or political or economic conditions in a particular country. In some foreign markets, there may not be protection against failure by other parties to complete transactions. It may
not be possible for the Fund to repatriate capital, dividends, interest, and other income from a particular country or governmental entity. In addition, a market swing in one or more countries or regions where the Fund has invested a significant
amount of its assets may have a greater effect on the Funds performance than it would in a more geographically diversified portfolio.
Eurozone
Risk. A number of countries in the European Union (EU) have experienced, and may continue to experience, severe economic and financial difficulties. In particular, many EU nations are susceptible to economic risks
associated with high levels of debt, notably due to investments in sovereign debt. As a result, financial markets in the EU have been subject to increased volatility and declines in asset values and liquidity. Responses to these financial problems
by European governments, central banks, and others, including austerity measures and reforms, may not work, may result in social unrest, and may limit future growth and economic recovery or have other unintended consequences. The risk of investing
in securities in the European markets may also be heightened due to the referendum in which the United Kingdom voted to exit the EU (known as Brexit). There is considerable uncertainty about how Brexit will be conducted, how negotiations
of necessary treaties and trade agreements will conclude, or how financial markets will react. To the extent that the Fund has exposure to European markets or to transactions tied to the value of the euro, these events could negatively affect the
value and liquidity of the Funds investments. All of these developments may continue to significantly affect the economies of all EU countries, which in turn may have a material adverse effect on the Funds investments in such countries,
other countries that depend on EU countries for significant amounts of trade or investment, or issuers with exposure to debt issued by certain EU countries.
Geographic Investment Risk. To the extent that the Fund invests a significant portion of its assets in a particular country or
geographic region, the Fund will generally have more exposure to certain risks due to possible political, economic, social, or regulatory events in that country or region. Adverse developments in certain regions could also adversely affect
securities of other countries whose economies appear to be unrelated and could have a negative impact on the Funds performance.
Nondiversification Risk. The Fund is classified as nondiversified under the Investment Company Act of 1940, as amended (1940
Act). This gives the Funds portfolio managers more flexibility to hold larger positions in a smaller number of securities. As a result, an increase or decrease in the value of a single security held by the Fund may have a greater impact
on the Funds NAV and total return.
Methodology and Model Risk. Neither the Fund nor Janus Capital can offer assurances that
tracking the Underlying Index will capture the growth of companies positioned to benefit from servicing the obese, or be appropriate for every investor seeking a particular risk profile. Underlying Index risks include, but are not limited to, the
risk that the factors used to determine the components of the Underlying Index, as applied by the Index Provider in accordance with the Underlying Index methodology, might not select securities that individually, or in the aggregate, are positioned
to benefit from servicing the obese.
Passive Investment Risk. The Fund is not actively managed and therefore the Fund might not
sell shares of a security due to current or projected underperformance of a security, industry or sector, unless that security is removed from the Underlying Index or the selling of shares is otherwise required upon a rebalancing of the Underlying
Index.
4½The Obesity ETF
Early Close/Trading Halt Risk. An exchange or market may close or issue trading halts on
specific securities, or the ability to buy or sell certain securities or financial instruments may be restricted, which may result in the Fund being unable to buy or sell certain securities or financial instruments. In such circumstances, the Fund
may be unable to rebalance its portfolio, may be unable to accurately price its investments and/or may incur substantial trading losses.
Index
Tracking Risk. The Funds return may not match or achieve a high degree of correlation with the return of the Underlying Index. To the extent the Fund utilizes a sampling approach, it may experience tracking error to a
greater extent than if the Fund sought to fully replicate the Underlying Index. In addition, the Fund may hold fewer than the total number of securities in the Underlying Index. Further, the Fund may hold securities or other investments not included
in the Underlying Index but which Janus Capital believes will help the Fund track the Underlying Index. Such investments may not perform as expected.
Index Provider Risk. The Fund seeks to achieve returns that generally correspond, before fees and expenses, to the performance of the
Underlying Index, as published by the Index Provider. There is no assurance that the Index Provider will compile the Underlying Index accurately, or that the Underlying Index will be determined, composed or calculated accurately. While the Index
Provider gives descriptions of what the Underlying Index is designed to achieve, the Index Provider generally does not provide any warranty or accept any liability in relation to the quality, accuracy or completeness of data in such index, and it
generally does not guarantee that the Underlying Index will be in line with its methodology. Errors made by the Index Provider with respect to the quality, accuracy and completeness of the data within the Underlying Index may occur from time to time
and may not be identified and corrected by the Index Provider for a period of time, if at all. Therefore, gains, losses or costs associated with Index Provider errors will generally be borne by the Fund and its shareholders.
Trading Issues Risk. Although Fund shares are listed for trading on The NASDAQ Stock Market LLC (NASDAQ), there can be no
assurance that an active trading market for such shares will develop or be maintained. The lack of an active market for Fund shares, as well as periods of high volatility, disruptions in the creation/redemption process, or factors affecting the
liquidity of the underlying securities held by the Fund, may result in the Funds shares trading at a premium or discount to its NAV. If an investor purchases shares at a time when the market price is at a premium to the NAV or sells at a time
when the market price is at a discount to the NAV, the investor may sustain losses.
Trading in Fund shares may be halted due to market conditions or for
reasons that, in the view of the NASDAQ, make trading in Fund shares inadvisable. In addition, trading is subject to trading halts caused by extraordinary market volatility pursuant to the NASDAQ circuit breaker rules. There can be no
assurance that the requirements of the NASDAQ necessary to maintain the Funds listing will continue to be met or will remain unchanged. During a flash crash, the market prices of the Funds shares may decline suddenly and
significantly. Such a decline may not reflect the performance of the portfolio securities held by the Fund. Flash crashes may cause Authorized Participants and other market makers to limit or cease trading in the Funds shares for temporary or
longer periods. Shareholders could suffer significant losses to the extent that they sell shares at these temporarily low market prices.
Fluctuation
of NAV. The NAV of the Fund shares will generally fluctuate with changes in the market value of the Funds securities holdings. The market prices of shares will generally fluctuate in accordance with changes in the
Funds NAV and supply and demand of shares on the NASDAQ. An absence of trading in shares of the Fund, or a high volume of trading in the Fund, may result in trading prices that differ significantly from the Funds NAV. It cannot be
predicted whether Fund shares will trade below, at or above the Funds NAV. If an investor purchases shares at a time when the market price is at a premium to the NAV of the shares or sells at a time when the market price is at a discount to
the NAV of the shares, then the investor may sustain losses. Further, the securities held by the Fund may be traded in markets that close at a different time than the NASDAQ. Liquidity in those securities may be reduced after the applicable closing
times. Accordingly, during the time when the NASDAQ is open but after the applicable market closing, bid-ask spreads and the resulting premium or discount to the Fund shares NAV may widen. Similarly, the NASDAQ may be closed at times or days
when markets for securities held by the Fund are open, which may increase bid-ask spreads and the resulting premium or discount to the Fund shares NAV when the NASDAQ re-opens.
Authorized Participant Risk. The Fund may have a limited number of financial institutions that may act as Authorized Participants
(APs). Only APs who have entered into agreements with the Funds distributor may engage in creation or redemption transactions directly with the Fund. To the extent that those APs exit the business or are unable to process creation
and/or redemption orders, and no other AP is able to step forward to create and redeem in either of these cases, shares may trade like closed-end fund shares at a premium or a discount to NAV and possibly face delisting.
5½The Obesity ETF
Securities Lending Risk. The Fund may seek to earn additional income through lending its
securities to certain qualified broker-dealers and institutions. There is the risk that when portfolio securities are lent, the securities may not be returned on a timely basis, and the Fund may experience delays and costs in recovering the security
or gaining access to the collateral provided to the Fund to collateralize the loan. If the Fund is unable to recover a security on loan, the Fund may use the collateral to purchase replacement securities in the market. There is a risk that the value
of the collateral could decrease below the cost of the replacement security by the time the replacement investment is made, resulting in a loss to the Fund.
An investment in the Fund is not a bank deposit and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government
agency.
The following information provides some indication of the risks of investing in the Fund by showing how the Funds
performance has varied over time. The bar chart depicts the change in performance from year to year during the periods indicated. The table compares the Funds average annual returns for the periods indicated to a broad-based securities market
index and the index the Fund seeks to track. The indices are not available for direct investment. All figures assume reinvestment of dividends and distributions.
The Funds past performance (before and after taxes) does not necessarily indicate how it will perform in the future. Updated performance information
is available at janushenderson.com/performance or by calling 1-800-668-0434.
The Obesity ETF
|
Annual Total Returns (calendar year-end)
|
|
Best Quarter: 4th Quarter
2019 13.94% Worst Quarter: 4th Quarter 2018 16.28%
|
|
|
|
|
|
|
|
|
|
Average Annual Total Returns (periods ended 12/31/19)
|
|
|
|
|
|
|
|
|
1 year
|
|
|
Since
Inception
6/8/2016
|
|
The Obesity ETF
|
|
|
|
|
|
|
|
|
Return Before Taxes
|
|
|
20.93
|
%
|
|
|
13.13
|
%
|
Return After Taxes on Distributions
|
|
|
20.75
|
%
|
|
|
12.98
|
%
|
Return After Taxes on Distributions and Sale of Fund
Shares
|
|
|
12.50
|
%
|
|
|
10.32
|
%
|
Solactive Obesity Index(1)
(reflects no deductions for fees, expenses or taxes)
|
|
|
21.26
|
%
|
|
|
13.52
|
%
|
MSCI All Country World Index(1)
(reflects no deductions for fees, expenses or taxes, except foreign withholding taxes)
|
|
|
26.60
|
%
|
|
|
11.60
|
%
|
(1)
|
Index performance shown in the table is the total return, which assumes reinvestment of any dividends and
distributions during the time periods shown.
|
After-tax returns in the table above are calculated using the historical highest individual
U.S. federal marginal income tax rates and do not reflect the impact of state or local taxes. Actual after-tax returns depend on your individual tax situation and may differ from those shown in the preceding table. The after-tax return information
shown above does not apply to Fund shares held through a tax-advantaged account, such as a 401(k) plan or an IRA.
6½The Obesity ETF
Investment Adviser: Janus Capital Management LLC
Portfolio Managers: Benjamin Wang, CFA, is Co-Portfolio Manager of the Fund, which he has co-managed since inception. Scott M.
Weiner, DPhil, is Co-Portfolio Manager of the Fund, which he has co-managed since inception.
|
PURCHASE AND SALE OF FUND SHARES
|
Unlike shares of traditional mutual funds, shares of the Fund are not individually redeemable and may only be purchased or
redeemed directly from the Fund at NAV in large increments called Creation Units (25,000 or more shares per Creation Unit) through certain participants, known as Authorized Participants. Janus Capital may modify the Creation
Unit size with prior notification to the Funds Authorized Participants. See the ETF portion of the Janus Henderson website for the Funds current Creation Unit size. The Fund will generally issue or redeem Creation Units in exchange for
portfolio securities (and an amount of cash) that the Fund specifies each day. Except when aggregated in Creation Units, Fund shares are not redeemable securities of the Fund.
Shares of the Fund are listed and trade on the NASDAQ, and individual investors can purchase or sell shares in much smaller increments for cash in the
secondary market through a broker. These transactions, which do not involve the Fund, are made at market prices that may vary throughout the day and differ from the Funds NAV. As a result, you may pay more than NAV (at a premium) when you
purchase shares, and receive less than NAV (at a discount) when you sell shares, in the secondary market.
The Funds distributions are taxable, and will be taxed as ordinary income or capital gains, unless you are investing
through a tax-advantaged arrangement, such as a 401(k) plan or an individual retirement account (in which case you may be taxed at ordinary income tax rates upon withdrawal of your investment from such account). A sale of Fund shares may result in a
capital gain or loss.
|
PAYMENTS TO BROKER-DEALERS AND OTHER FINANCIAL
INTERMEDIARIES
|
If you purchase the Fund through a broker-dealer or other financial intermediary (such as a bank), Janus Capital and/or its
affiliates may pay broker-dealers or intermediaries for the sale and/or maintenance of Fund shares and related services. These payments may create a conflict of interest by influencing the broker-dealer or other intermediary and your salesperson to
recommend the Fund over another investment. Ask your salesperson or visit your financial intermediarys website for more information.
7½The Obesity ETF
Janus Henderson Mortgage... (AMEX:JMBS)
Historical Stock Chart
From Dec 2024 to Jan 2025
Janus Henderson Mortgage... (AMEX:JMBS)
Historical Stock Chart
From Jan 2024 to Jan 2025